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The effect of gangliosides and cholera enterotoxin on 1251 choriogonadotropin binding, cAMP 
formation, protein kinase activation and progesterone production have been studied in isolated rat 
ovarian interstitial cells. A close correlation was observed between the amount of adenosine 3' : 5'- 
monophosphate (CAMP) produced in the cells and the extent of the activation of protein kinase 
in response to cholera enterotoxin and choriogonadotropin. Similarly cholera enterotoxin, like 
choriogonadotropin, stimulated steroidogenesis in a dose-dependent and time-dependent manner. 
Addition of highly purified ganglioside mixtures abolished the stimulatory effect of cholera 
enterotoxin on cAMP and progesterone responses, while these agents had no effect on chorio- 
gonadotropin-stimulated responses. Similar results were also obtained when different lutropin 
preparations were tested. Pretreatment of ovarian cells with gangliosides did not show any 
enhancement in the extent of steroidgenesis stimulated by toxin or trophic hormones compared to 
that seen with untreated cells. 
Both gahgliosides and cholera enterotoxin failed to block 1251-labelled choriogonadotropin 
binding to ovarian cells. Individual gangliosides GD1,, GD1 b, GT1 and GMl [designated according 
to Svennerholm (1963) 1. Neurochem. 10, 613-6231 did not modify gonadotropin binding to 
ovarian cells. Similarly gangliosides isolated from rat ovary, bovine corpus luteum and rat brain 
also lacked the ability to modify 1251-labelled choriogonadotropin binding to cells. Analysis of 
ovarian cells for gangliosides indicated that major ganglioside was GM3 with trace amounts of other 
gangliosides including GMI and more complex gangliosides. 
The results presented in this communication suggest that gonadotropin binding and subsequent 
cAMP and progesterone production are not influenced directly by gangliosides. In contrast, 
choleragen-stimulated cellular events in the ovarian cells were completely inhibited by gangliosides. 
This suggests that these two agents exert their effects on the responsive system by interacting 
through separate components on the cell surface. 
The mechanisms by which gonadotropins (lutropin 
and choriogonadotropin) regulate steroidgenesis in 
the ovary are not fully understood. Gonadotropin 
receptors located in the plasma membrane of target 
cells are now recognized as the specific initial mediators 
Abbreviations. CAMP, adenosine 3' :  5'-monophosphate; GMI, 
galactosyl - N -  acetylgalactosaminyl- ( N -  acetylneuraminyl) -galacto- 
sylglucosylceramide; G M ~ ,  N-acetylgalactosaminyl-(N-acetylneur- 
aminy1)-galactosylglucosylceramide; GM3, N-acetylneuraminyl- 
galactosylglucosylceramide; GDI,, N-acetylneuraminylgalactosyl- 
N -  acetylgalactosaminyl- ( N -  acetylneuraminyl) - galactosylglucosyl- 
ceramide; GDII,, galactosyl-N-acetylgalactosaminyl-(N-acetylneur- 
aminyl-N-acetylneuraminyl)-galactosylglucosylceramide; G T ~ ,  N- 
acetylneuraminylgalactosyl -N - acetylgalactosaminyl - ( N  - acetyl- 
neuraminyl-N-acetylneuraminyl)-galactosylceramide. Gangliosides 
are designated according to Svennerholm [78 1. 
through which gonadotropins influence cellular events 
including steroidogenesis [l - 191. The available ev- 
idence suggests that the initial binding of hormone to 
cell surface receptor leads to the activation of mem- 
brane-bound adenylate cyclase, accumulation of 
CAMP, activation of cAMP dependent protein 
kinase(s) and subsequent stimulation of steroido- 
genesis [l-10, 20-281. However, little is known 
about the involvement and role of various membrane 
components in receptor-mediated gonadotropin action 
including regulation of cAMP and steroid responses 
Cholera enterotoxin (choleragen), a protein of 
M ,  about 84000 [29] secreted by Vibrio cholera, has 
been shown to stimulate adenylate cyclase in a 
[ l -  10,20-281. 
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variety of mammalian tissues [30,31] and in some cases 
increases the responsiveness of adenylate cyclase to 
hormonal stimulation. The initial event in the action 
of choleragen involves a high-affinity binding to cell 
surface receptor sites [32-371 believed to be 
ganglioside G M ~  [32 - 34,36 - 491. Ganglioside G M ~  
has been shown to block the biological effects of 
the toxin in several systems [32 - 501. Recently, com- 
parison of a partial sequence [51] and the complete 
sequence [52] of the p chain of the cholera enterotoxin 
with the p chain of the glycoprotein hormones such 
as human choriogonadotropin, lutropin, follitropin, 
and thyrotropin, revealed that a segment comprising 
the first 40 residues of the toxin is chemically similar 
to an internal segment of the hormones. The molecular 
weights of the p chain of the glycoprotein hormones 
and the p chain of cholera toxin are similar. Further- 
more, like the cholera enterotoxin receptor [32 - 34, 
36 - 491, it was postulated that ganglioside or a gang- 
lioside-like structure may be an integral part of 
glycoprotein hormone receptors [53 - 581. More re- 
cently gangliosides have been shown to interact 
with thyrotropin, lutropin and human choriogonado- 
tropin and in turn block their binding to respective 
receptors [54,56 - 581. While these findings provide 
strong evidence for the idea that the gangliosides may 
be part of glycoprotein hormone receptors, we are 
unaware of any evidence which suggests that ganglio- 
sides modify biological responses elicited by these 
hormones. 
Previous studies from this laboratory have shown 
that collagenase-dispersed rat ovarian interstitial cells 
respond to gonadotropin with increases in cAMP 
accumulation [7,9,23,25 - 271, protein kinase activity 
[22,23,25 - 271 and steroidogenesis [7,9,26,28]. In the 
present paper we have investigated in this system the 
effect of ovarian gangliosides and gangliosides from 
other sources on '251-labelled choriogonadotropin 
binding and the effect of these agents on subsequent 
gonadotropin-stimulated cAMP and progesterone re- 
sponses. 
EXPERIMENTAL PROCEDURE 
Muter i d s  
Cholera enterotoxin was purchased from Schwarz/ 
Mann (Orangeburg, N. Y., U.S.A.). Highly purified 
bovine brain gangliosides were purchased from ICN 
Pharmaceuticals, (Irvine, Calif., U.S.A.). Individual 
gangliosides were isolated by preparative thin-layer 
chromatography of commercially purchased ganglio- 
sides. Precoated Silica Gel G thin-layer plates 0.25 mm 
(20 x 20 cm) were obtained from Analtech Inc. (Ne- 
wark, Del., U.S.A.). Precoated silica gel 60 Fz54 thin- 
layer plates were purchased from Brinkman Instru- 
ment Inc. (DesPlaines, Ill., U.S.A.). Unisil and DEAE- 
Sephadex A-25 (40 to 120 pm) were supplied by 
Clarkson Laboratories (Williamsport, Pa., U. S .A .), 
and Pharmacia Fine Chemicals (Piscataway, N.J., 
U.S.A.), respectively. Purified human chorionic go- 
nadotropin (1 1 500 Ujmg) was obtained from Dr R. E. 
Canfield (Columbia University Collge of Physicans 
and Surgeons, New York, N.Y., U.S.A.) through 
the Center for Population Research, National Insti- 
tutes of Child Health and Human Development, 
Bethesda, Md., U.S.A. Ovine lutropin (NIH-LH Sl8) 
and bovine lutropin (NIH-LH-B9) were gifts of Hor- 
mone Distribution Program, National Institutes of 
Arthritis, Metabolism and Digestive Diseases, Bethes- 
da, Md., U.S.A. All other chemicals used were of 
reagent grade. Eagle's minimum essential medium 
with Earle's salts (medium 109) was purchased from 
Grand Island Biological Company (Grand Island, 
N. Y., U.S.A.). 1251-labelled choriogonatotropin was 
prepared as described earlier [9,18,19]. 
Preparation of Rat Ovarian Cells 
Ovarian interstitial cells were prepared from 
25-day-old rat ovaries (Sprague Dawley) by the 
procedure described earlier [7,9]. 
Incubation Conditions for Choriogonadotropin, 
Lutropin and Cholera Enterotoxin Stimulation 
of Progesterone Production by Ovarian Cells 
Unless otherwise stated, cells (2.5-4 x lo6 cells) 
were incubated in a final volume of 0.4 ml of medium 
109 containing 0.1 % bovine serum albumin (w/v) in 
the presence and absence of added hormone. In- 
cubations were carried out at 37 "C in an atmosphere of 
OZ/COZ (95/5 %, v/v) usually for 3 h. Other details, if 
any, are given under individual tables and figures. 
Radioimmunoassay for  Progesterone 
Following incubation as described above, the 
sample tubes were placed in a boiling water bath for 
3 min and 0.6 ml water and 10 pl (z 10000 counts/ 
min) of [1,2-3H]progesterone to monitor recovery 
were added and the samples left in the cold overnight. 
After 12 h, samples were extracted with light petroleum 
and assayed for progesterone by radioimmunoassay 
as described earlier [7,9]. 
Gonadotropin and Cholera Enterotoxin Stimulation 
of CAMP 
Cells (2.5-4 x lo6 cells) were incubated in a final 
volume of 0.4 ml of medium 109 containing 0.1 % 
bovine serum albumin (w/v), in the presence or 
absence of 0.5 mM 3-isobutyl-1-methylxanthine and 
where required choriogonadotropin, lutropin or chol- 
era enterotoxin were also added. After incubation at 
37 "C for 60 min in the presence of Oz/C02 (95/5 %, 
S. Azhar and K. M. J .  Menon 19 
v/v) cells and medium were processed and assayed for 
cAMP according to Gilman [59] as described 
previously [25]. 
Activation of CAMP- Dependent Protein Kinases 
by Gonadotropins and Cholera Enterotoxin 
Cell suspension (1.2 x lo7 cells) in 0.4 ml of 
medium 109 containing 0.1 % bovine serum albumin 
(w/v) were incubated with or without test substance 
at 37°C in the presence of 0 & 0 2  (95/5%, v/v). 
After incubation for 40 min the cells were centrifuged 
(400 x g,  5 min) and homogenized in 200 pl of 10 mM 
Tris-HC1 buffer pH 7.2; containing 1 mM EDTA and 
0.5 mM 3-isobutyl-l-methylxanthine. Following cen- 
trifugation at 20000 x g for 20 min in the cold (4 "C), 
the clear supernatant was used to assay protein kinase 
activity by the method of Corbin et al. [60]. The 
incubation mixture contained in a final volume of 
75 pl, 12 mM potassium phosphate pH 6.8, 20 mM 
NaF, 4 mM MgC12, 0.22 mM [Y-~~PIATP (90000 to 
100000 counts x min-' x mmol-I), 10mg/ml ofmixed 
histone, cellular extract and where required 2 pM 
CAMP. In each case the reaction was stopped after 
5 min of incubation at 30°C by spotting 50 pl of the 
reaction mixture on Whatman 3 MM filter paper disc 
and immersing in ice-cold 10 % trichloroacetic acid as 
described by Corbin and Reiman [61] with the modifi- 
cation that disc were washed four times with 10% 
trichloroacetic acid with at least one overnight wash 
[27]. They were then washed for 30 min in ethanol 
and 30 min in diethyl ether before drying and counting 
in a Beckman LS230 liquid scintillation spectro- 
photometer in vials containing 10 ml of a solution of 
4 g of Omniflour/l toluene. Protein kinase activity was 
expressed as the activity ratio, i.e. the ratio of activity 
in the absence of cAMP to that in the presence of 
2 yM cAMP [60]. 
Choriogonadotropin Binding to Ovarian Cells 
The method used for the binding assay of 1251- 
labelled choriogonadotropin to intact interstitial cells 
was identical to that described by Clark and Menon 
[91. 
Gangliosides Isola t ion, Pur $ica t ion 
and Characterization 
Ovarian gangliosides were isolated and purified 
using the procedure described by Ledeen et al. [62]. 
Ovarian cells equivalent to 1 g ovaries were homo- 
genized in 20 ml of chloroform/methanol ( l / l ,  v/v) 
and the suspension was centrifuged at 1000 x g for 
30 min. The supernatant was saved, and the pellet was 
reextracted twice with 10 volumes of the same solvent. 
The combined supernatants were diluted to 200 ml 
giving an adjusted composition of chloroform/ 
methanol/water (30/60/8, v/v/v). 
The entire 200 ml sample in chloroform/methanol/ 
water (30/60/8, v/v/v) was applied to a previously 
equilibrated DEAE-Sephadex column at a rate of 
approximately 1 ml/min according to the procedure 
of Ledeen et al. [62]. The first fraction (I) consisted 
of 300 ml chloroform/methanol/water (30/60/8, v/v/v) 
(sample volume + 100 ml), and the second frac- 
tion (11) was eluted with 180 ml of chloroform/ 
methanol/0.8 M sodium acetate (30/60/8, v/v/v). Frac- 
tion I1 was evaporated to dryness and the residue was 
resuspended in 16 ml of 0.1 M NaOH in methanol and 
incubated at 40°C for 3 h. The reaction mixture was 
acidified to pH 2 by dropwise addition of 1 M HC1 in 
an ice bath, and after the addition of 1 ml of 0.5 M 
EDTA, the mixture was dialyzed against distilled 
water for 2 days. The dialyzed material was 
lyophilized, and the resulting residue was suspended 
in 20 ml of chloroform/methanol (l / l ,  v/v) and 
solubilized with mild sonication. Following centrif- 
ugation the filtrates were evaporated to dryness. The 
dried material was suspended in 4 ml of chloroform/ 
methanol (1 / l ,  v/v) ; 6 ml of chloroform was then added 
and the mixture was applied to a Unisil (2 g) column 
packed and equilibrated with chloroform. The column 
was first eluted with 140 ml of chloroform/methanol 
(SOj20, v/v) at a flow rate of 0.5 ml/min. The adsorbed 
gangliosides were next eluted with 300 ml of chloro- 
form/methanol (131, v/v). The ganglioside fraction 
was evaporated to dryness. The dry material was 
dissolved in chloroform/methanol(2/1, v/v), sonicated, 
and cleared by centrifugation. The quantitative and 
qualitative determinations of ganglioside N-acetyl- 
neuraminic acid were performed on this supernatant. 
Two samples of about 10-20 pg of N-acetyl- 
neuraminic acid were taken and the quantity of 
sialic acid was determined by the resorcinol method 
of Svennerholm [64], using butanol/butylacetate 
(15/85, v/v) to extract the chromophore [65]. The 
color was read at 580 nm in a Gilford spectrophotom- 
eter using free sialic acid as standard. 
Thin-layer chromatography was carried out on 
precoated plates of silica gel G (Analtech Inc.) or 
silica gel F254 plates (Brinkman Inc.) (20 x 20 cm); 
10 to 12 pg of total N-acetylneuraminic acid and about 
10 pg reference standards were applied. The solvent 
mixtures used [66] were chloroform/methanol/water 
(60/35/8, v/v/v) containing 20 mg CaC12 . 2 H 2 0  per 
100 ml solvent and chloroform/methanol/2.5 M 
NH40H (60/35/8, v/v/v) containing 20 mg KC1 per 
100 ml of solvent. Chromatography was performed 
for 2.5 h twice in a tank at room temperature (25 "C). 
Gangliosides were localized by resorcinol spray [67]. 
For the quantitative determination of individual 
gangliosides, the bands were visualized by brief 
exposure to iodine vapors. After iodine sublimation, 
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Table 1. Effect of cholera enterotoxin and choriogonadotropin on 
c A M P  accumulation and protein kinase activation in isolated rat 
interstitial cells 
Ovarian cells (3 x lo6 cells for cAMP or 1.3 x lo7 cells for protein 
kinase) were incubated in a final volume of 0.4 ml medium 109 
containing 0.1 % bovine serum albumin and indicated concentra- 
tions of choriogonadotropin or cholera enterotoxin in the presence 
or absence of 0.5 mM 3-isobutyl-I-methylxanthine. Following in- 
cubation for 60 min in the case of cAMP and 40 min for protein 
kinase in the presence of OZ/COz (95j5 %) at 37 "C the tubes were 
processed for respective assays as discussed under Experimental 
Procedure. Results are mean of triplicate samples on duplicate de- 
terminations S.E.M. 
Additions cAMP Protein kinase 
(- CAMP/+ CAMP) 
pmol I pg DNA ~ 
None 0.55 k 0.05 0.162 * 0.029 
3-Isobutyl-I -methyl- 
xanthine (0.5 mM) 0.96 k 0.02 0.209 * 0.027 
Choriogonadotropin 
(1 pg/ml) 3.60 k 0.22 0.462 f 0.086 
Cholera enterotoxin 
(1 pgLg/ml) 2.93 k 0.26 0.483 f 0.030 
Choriogonadotropin 
(1 pg/mI) + 3- Isobutyl-I- 
methylxanthine 
(0.5 mM) 12.52 * 0.51 0.805 + 0.04 
Cholera enterotoxin 
(1 pg/ml) + 3-Isobutyl-l- 
methylxanthine 
(0.5 mM) 14.92 k 0.38 0.937 0.035 
marked areas of plates were scraped, eluted as de- 
scribed by Ledeen [62], and the sialic acid contents 
determined spectrophotometrically [64,65]. 
RESULTS 
Effect of Cholera Enterotoxin on CAMP Accumulation 
and Protein Kinase Activation and Steroidogenesis 
in Rat Ovarian Cells 
Incubation of ovarian cells with choleragen or 
choriogonadotropin produced an increase in their 
cAMP content (Table l), and addition of 0.5 mM 
3-isobutyl-1-methylxanthine potentiated the action 
of both toxin and hormone. Similarly, cells incubated 
with 1 pg/ml of either cholera enterotoxin or chorio- 
gonadotropin increased protein kinase activity ratio 
(-cAMP/+cAMP), and as in the case of CAMP, 
addition of phosphodiesterase inhibitor -potentiated 
the action of both these agents (Table 1). Since in rat 
ovarian cells gonadotropin stimulates protein kinase 
activity by increasing the intracellular levels of cAMP 
[22,23,25], the demonstration of protein kinase stim- 
ulation by choleragen suggests that the toxin mimics 
the hormonal response which is thought to be mediated 
via the adenylate cyclase-CAMP system [7,9]. Cholera 
enterotoxin also stimulated progesterone production 
in a dose-dependent manner. Although choriogonado- 
tropin stimulated a maximum amount of progesterone 
production after 2 h of incubation, a 3 h incubation 
i c 1  ? :  
Mixed gangliosides (&g.rn<') 
* I 
Fig. 1. Action of exogenously added mixed gangliosides on progesterone synthesis by ovarian cells stimulated by cholera enterotoxin and 
choriogonadotropin. Different concentrations of cholera enterotoxin or choriogonadotropin were incubated with bovine brain mixed ganglio- 
sides in medium 109 containing 0.1 % bovine serum albumin in a volume of 0.3 ml at 35 "C for 30 min. Following preincubation 0.1 ml 
ovarian cells (3 x l o 6  cells) were added and incubation continued for an additional 3 h at 37 "C in an atmosphere of Oz/COz (95/5 %, v/v). 
Following incubation, samples were extracted and assayed for progesterone by radioimmunoassay as described in Experimental Procedure. 
The concentrations of various agents shown in the figure were the final concentrations after the addition of cells. (GO) No addition; 
(A-A) cholera enterotoxin (2.5 ng/ml); (A-A) cholera enterotoxin (10 ng/ml); (c- . -0) cholera enterotoxin (100 ng/ml); ( L O )  
cholera enterotoxin (lwg/ml); (-a) cholera enterotoxin (2.5 pg/ml); (Y-V) cholera enterotoxin (10 pg/ml); (0-0) choriogonado- 
tropin (1 ng/ml); (v-V) choriogonadotropin (10 ng/ml). Bar C represents progesterone production without any test substance. Bars 1 
to 6 represent progesterone production in the ovarian cells in response to 2.5, 10, 100, 2500, 10000 ng/ml of cholera enterotoxin without 
added gangliosides. Hatched bars 7 and 8 represent progesterone production elicited by 1 and 10 ng/ml of choriogonadotropin. Results are 
the mean of triplicate samples on duplicate determinations & S.E.M. 
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period was required to reach maximum steroid 
production in response to choleragen (data not 
shown). Results presented so far suggest that chorio- 
gonadotropin and cholera enterotoxin effectively and 
almost equally stimulate cAMP and progesterone 
responses in ovarian cells. However, it is important to 
mention here that since these cells were treated with 
collagenase and may therefore not entirely represent 
the situation in vivo, further experiments reported 
below deal with effect of gangliosides on these two 
responses as well as on the binding of '251-labelled 
choriogonado ropin to ovarian cells. 
Effect of Exogenous Gangliosides on Progesterone 
Production and C A M P  Formation Stimulated 
by Cholera Enterotoxin and Gonadotropin 
Since gangliosides have been previously reported 
to block binding of thyrotropin, lutropin, and chorio- 
gonadotropin to their receptors [54,56- 581 and also 
to modify cholera enterotoxin responses in other 
biological systems [33  - 47,501, we tested the pos- 
sibility that gonadotropin-ganglioside or cholera en- 
terotoxin-ganglioside interactions could lead to sub- 
sequent modification of progesterone and cAMP 
responses. Results presented in Fig.1 show that 
incubation of cholera enterotoxin with gangliosides 
blocked the steroidogenic effect of choleragen in a 
dose-dependent manner. Addition of 25 pg/ml mixed 
gangliosides completely blocked stimulation of ste- 
roidogenesis by 1 ng or 10 ng/ml of enterotoxin. Simi- 
larly, higher concentrations of gangliosides effectively 
blocked progesterone production promoted by higher 
concentrations of cholera enterotoxin (Fig. 1). On the 
other hand, the steroidogenic response to chorio- 
gonadotropin was unaffected by the same concentra- 
tions of gangliosides. Similar results were also obtained 
when different preparations of lutropin were tested as 
stimulators of steroidogenesis in rat ovarian cells. As 
in the case of choriogonadotropin, different concentra- 
tions of gangliosides failed to modulate lutropin- 
stimulated steroidogenesis (Table 2). 
The results presented in Table 3 also show that 
gangliosides completely blocked the increase in cAMP 
levels caused by cholera enterotoxin. However, gan- 
gliosides were completely ineffective against gonado- 
tropin-stimulated cAMP production (Table 3 ) .  Simi- 
larly, we could not detect any change in 1251-labelled 
chosiogonadotropin binding to rat ovarian cells in 
the presence of gangliosides. Pretreatment of lZ5I- 
labelled choriogonadotropin with different concen- 
trations of mixed bovine brain gangliosides (up to 
500 pg/ml) did not affect subsequent binding of the 
hormone to the cells (Fig. 2) .  Similarly, cholera entero- 
toxin did not compete with gonadotropin binding, 
while under identical experimental conditions, 250 ng/ 
ml unlabelled choriogonadotropin completely blocked 
Table 2. Effect of mixed gangliosides on gonadotropins and rholeru 
enterotoxin rtimulation progesterone synthesis by rut ovarian cells 
Incubation conditions were the same as described in Fig. 1. Results 
are f S.E.M. 
~~ 
Additions Bovine brain mixed gangliosides 
(Pgimu 
0 2.5 25 100 
- ~ 
pg progesterone/pg DNA 
_ _  ~ 
















100ng/ml 201 + I 0  48 f 6 13 k 5 7.3f 1.6 
the binding of '251-labelled choriogonadotropin to 
ovarian cells (Fig. 2). 
Lack of Effect of Different Gangliosides and Mixed 
Gangliosides of Different Composition 
on 12' I-labelled Choriogonadotropin Binding 
to Ovarian Cells 
Since in F ig2  we used only one type of mixed 
gangliosides (bovine), in subsequent experiments we 
also tested the effect of gangliosides of variable com- 
position on 1251-labelled choriogonadotropin binding 
to ovarian cells. Pretreatment of choriogonadotropin 
or ovarian cells with gangliosides from rat ovary or 
from bovine brain also could not produce any change 
in the 1251-labelled choriogonadotropin binding ac- 
tivity. Further chromatographically pure individual 
gangliosides GTI, GMI, G D I ~  and G D I ~  up to 100 pg/ml 
also failed to modulate gonadotropin receptor inter- 
action on ovarian cells. Similarly, mixed gangliosides 
isolated from rat ovary, bovine corpus luteum and 
rat brain did not affect gonadotropin binding to cells 
(Table 4). 
The results presented in Fig.3 show typical thin- 
layer chromatographic analyses of the gangliosides 
obtained from ovarian cells. The major ganglioside 
found in the intact cells was identified as ganglioside 
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Table 3. Effect of mixed gangliosides on CAMP synthesis by rat 
ovarian cells stimulated by choriogonadotropin, lutropin and cholera 
enterotoxin 
Cells (4 x lo6 cells) were incubated in a final volume of 0.4 ml of 
medium 109 containing 0.1 "/, bovine serum albumin, 0.5 mM 
3-isobutyl-l-methylxanthine, indicated concentrations of gonado- 
tropins or cholera enterotoxin, and where required, indicated con- 
centrations of gangliosides were also added. Before addition of 
cells, hormone and gangliosides were preincubated at 24 "C for 
30 min. Following addition of cells incubations were carried out 
at 37 "C for 60 min in the presence of 02/C02 (95/5). At the end of 
incubation samples were processed for cAMP determination as 
described in Experimental Procedure. Results are the mean of tri- 
plicate samples on duplicate determinations f S.E.M. Bovine 
brain mixed gangliosides were used in this study 
Additions cAMP 
None 
Mixed gangliosides (500 pg/ml) 
Cholera enterotoxin (10 ng/ml) 
Cholera enterotoxin (1 pg/ml) 
Choriogonadotropin (10 ng/ml) 
Choriogonadotropin (1 pg/ml) 
Lutropin [NIH-LH B9] (1 pg/ml) 
Lutropin [NIH-LH S18] (1 pg/ml) 
Cholera enterotoxin (10 ng/ml) 
Cholera enterotoxin (1 pg/ml) 
Choriogonadotropin (10 ng/ml) 
Choriogonadotropin (1 pg/ml) 
Lutropin [NIH-LH-B9] (1 pg/ml) 
Lutropin [NIH-LH-S18] (1 pg/ml) 
+ mixed gangliosides (500 pg/ml) 
+ mixed gangliosides (500 pg/ml) 
+ mixed gangliosides (500 pg/ml) 
+ mixed gangliosides (500 pg/ml) 
+ mixed gangliosides (500 pg/ml) 
+mixed gangliosides (500 pg/ml) 
pmol . pg DNA-' 
1.7 f 0.09 
1.0 + 0.04 
6.33 f 0.33 
14.92 f 0.38 
8.93 f 0.30 
12.52 f 0.51 
6.69 + 0.28 
5.74 * 0.11 
0.92 & 0.05 
1.13 f 0.06 
8.10 f 0.43 
11.32 f 0.2 
5.73 f 0.23 
5.81 k 0.44 
Table 4. Lack of e[fect of purified gangliosides and mixed ganglio- 
sides of various composition on '251-labelled choriogonadotropin 
binding to rat ovarian cells 
Incubation conditions were the same as described in Fig. 1 .  Ganglio- 
sides GMI, Go'., G ~ l b  and GT1 were isolated from brain mixed 
ganglioside preparation (ICN Pharmaceuticals) by preparative 
thin-layer chromatography [61]. Gangliosides from rat ovary and 
bovine corpus luteum were isolated according to Leeden et al. [61] 
as described under Experimental Procedure. Rat brain gangliosides 
were isolated according to Suzuki [62] .  The results are expressed 




counts x min-I x 100 pg 
DNA - 
Experiment 1 (Individual gangliosides) 
None - 









Experiment 2 (Mixed gangliosides) 
None - 
Rat ovary 50 
200 
Bovine corpus luteum 50 
200 
Rat brain 50 
200 
Bovine brain 200 
Choriogonadotropin 0.01 
7612 f 281 
8736 k 325 
8050 f. 328 
8258 f 219 
8179 k 122 
8187 f 759 
8113 & 342 
7888 & 382 
7455 f 176 
3656 f 784 
8939 f 430 
8029 f 4 
8259 f 262 
7510 f 75 
8141 151 
7845 f 187 
7961 f 142 
8080 f 534 
3785 + 62 
0.001 0.01 0.10 1D 10 100 1000 
Concentration (kg-rnl- ') 
Fig. 2. Lack of cholera enterotoxin and gangliosides effect on 1251-labelled choriogonadotropin binding of rat ovarian cells. '251-labelled 
choriogonadotropin (4 ng, 160000 counts/min) was preincubated with cholera enterotoxin, bovine brain mixed gangliosides or unlabelled 
choriogonadotropin for 30 min under the conditions described in Fig. 1. Following preincubation, 0.1 ml cells (5 x lo6 cells) were added 
and incubation continued for 30 min, after which cells were processed for the determination of bound radioactivity. Other details have 
been described in Experimental Procedure. (A-A) Cholera enterotoxin; (A-A) gangliosides; (-0) unlabelled choriogonadotropin. 
Hatched bar, 1251-labelled choriogonadotropin binding without any test substance. Results are mean of triplicate samples on duplicate 
determinations k S.E.M. 
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Fig. 3. Thin-layer chromatography of ganglioside extract of ovarian 
cells. Ganglioside extraction, purification and thin-layer chromato- 
graphic separation were carried out as described in Experimental 
Procedure 
G M ~ .  A significant amount of resorcinol-positive ma- 
terial from ovarian cell extract also migrated between 
gangliosides GM2 and GM3, and other faint resorcinol- 
positive material co-migrated with authentic ganglio- 
side G M ~ .  Some resorcinol-positive material migrated 
between gangliosides G D ~ ~  and GMI. 
Pretreatment of Ovarian Celts with Gangliosides 
on Subsequent Steroidogenesis in Response 
to Lutropin, Choriogonadotropin 
and Cholera Enterotoxin 
Since exogenous gangliosides can be spontaneously 
incorporated into the cell membrane [43,48,70], we 
tested the pretreatments of ovarian cells with ganglio- 
sides on subsequent steroidogenesis stimulated by 
gonadotropins and cholera enterotoxin. Pretreatment 
of ovarian cells with gangliosides did not result in any 
significant alterations of subsequent steroidogenic 
response elicited by any stimulator. Even very low 
concentrations of choleragen (2.5 ng/ml) failed to 
show enhanced steroidogenesis in cells pretreated 
with gangliosides. (Data not shown.) 
DISCUSSION 
An important step in the regulation of ovarian 
function by gonadotropin is the initial interaction of 
hormone with the receptor and the modulation of 
this process by other membrane constituents present 
in the intact cell. The use of cholera enterotoxin as a 
membrane probe has added new directions in the area 
of hormone-receptor interaction in the cell membrane 
and subsequent biological response. The initial step 
in the action of the toxin is the binding of the /3 subunit 
to the membrane receptor which is presumably 
the monosialoganglioside, G M l  [32 - 34,36 - 491, with 
the resultant stimulations of adenylate cyclase and 
cAMP in a wide variety of cell types [37,49,50, 
68-75]. In the present studies we have explored 
whether gangliosides or ganglioside-like structure are 
the part of membrane receptors for gonadotropin in 
ovary. We also examined the effect of gonadotropin- 
ganglioside interaction on the subsequent biological 
responses by hormone. 
Since gangliosides are normal cell membrane 
constituents whose carbohydrate moieties are exposed 
to the outside of the cells, it is likely that the previously 
observed gonadotropin-ganglioside interaction [56 - 
581 may involve the binding to the carbohydrate 
portion of the gangliosides on the cell membrane: 
The failure of gangliosides to inhibit 1251-labelled 
choriogonadotropin binding to ovarian cells suggests 
that the tropic hormone receptors in the present 
system are very specific and that the hormone receptor- 
interaction is a more complex phenomenon. These 
findings coupled with results on the lack of ganglio- 
side effect on cAMP and progesterone responses 
suggest that the tropic hormone exerts its effect 
through a different or additional mechanism from 
that of cholera enterotoxin, the nature of which 
remains to be determined. Recently, ganglioside 
inhibition of gonadotropins binding to rat testis 
plasma membrane has been described, in which the 
inhibition was shown to be the result of interaction 
between the hormone and the gangliosides rather than 
the membrane and glycolipids [57,58]. However, it 
was not clear whether the inhibition in gonadotropin 
binding to rat testis plasma membranes also parallels 
a corresponding change in the cell response. Since 
gangliosides GDi,, GDlb, GT1 and GMI interact with 
choriogonadotropin and lutropin to a greater extent 
than the other -gangliosides, the amount and type of 
bovine brain ganglioside [28,47,57,58,62,63,65] used 
as well as other gangliosides in the present experiments 
suggest that the ineffectiveness of these agents on 
gonadotropin-stimulated responses cannot be attri- 
buted to the nonavailability of the ganglioside to 
produce an effect. The inability of various purified 
gangliosides (Table 5) as well as gangliosides of dif- 
ferent composition (Table 6) to modulate "'I-la- 
belled choriogonadotropin binding activity further 
support the lack of involvement of gangliosides in 
gonadotropin receptor interaction. The inhibition of 
cholera enterotoxin stimulated cAMP and pro- 
gesterone responses by exogenous gangliosides sug- 
gests that these agents were indeed effective. The ob- 
servations further signify the complex nature of 
hormone-receptor interaction and subsequent bio- 
logical responses. The present study of ganglioside 
inhibition of cholera enterotoxin stimulated biological 
responses in ovarian cells agrees well with those 
reported for inhibition of biological effects of toxin 
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by gangliosides in other biological systems [38 - 47, 
501. 
The lack of cholera enterotoxin effect on lz5I- 
labelled choriogonadotropin binding to ovarian cells 
suggests that the binding sites of choleragen and 
gonadotropins are different. Since maximum stimu- 
latory doses of toxin did not modify the maximum 
progesterone production caused by choriogonado- 
tropin (unpublished results), the toxin effect may be 
brought about by the secondary changes within the 
cells, possibly through an increase of CAMP. Further- 
more, prior treatment of cells with gangliosides did 
not increase subsequent steroidogenesis promoted by 
either lutropin, choriogonadotropin or cholera entero- 
toxin. Previously Cuatrecasas [49] has demonstrated 
that the lypolytic action of cholera enterotoxin can 
be enhanced by prior treatment of fat cells with 
gangliosides. More recently Moss et al. [72] reported 
that GMl-deficient mouse fibroblasts that were un- 
responsive to choleragen when grown in chemically 
defined medium became responsive after binding 
exogenous ganglioside G M ~ .  However, binding of com- 
parable amounts of gangliosides G M ~ ,  GMZ and G D I ~  
to the cells did not restore responsiveness. Although 
these studies strongly support ganglioside G M ~  as the 
possible receptor for choleragen on cell surface 
receptors, there are reports which do not totally 
support this hypothesis. Kanfer et al. [48] recently 
carried out an extensive study on choleragen regulation 
of lypolysis in fat cells and their findings could not 
support ganglioside GMI as a native receptor for 
choleragen on these cells. Similarly, King et al. [76] 
attempted to correlate the quantitative relationship 
between the amount of toxin bound to pigeon erythro- 
cyte membrane and the extent of gangliosides GMI 
stimulation of cholera enterotoxin activation of adeny- 
late cyclase and suggested that the natural receptor 
for cholera enterotoxin may be more complex than 
ganglioside G M ~ .  Donta et al. [77] also investigated 
the role of gangliosides in relation to cholera entero- 
toxin stimulated steroidogenesis in adrenal tumor cells 
and concluded that ganglioside GM1 may not be a true 
representative receptor for choleragen in his system. 
From the various findings reported in the present 
communication, it is concluded that gonadotropin 
binding and the subsequent physiological responses 
were not influenced by gangliosides directly. Further- 
more, gonadotropin receptor interactions and sub- 
sequent biological responses in ovarian cells probably 
represent a more complex instance in which cells 
specially respond to receptor-mediated gonadotropin 
signals. 
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